Corrigendum to “New Treatment Option for COPD

Two Long-Acting Bronchodilators in a Single Metered Dose Inhaler” (The American Journal of Medicine (2017) 130(11) (1251–1254), (S0002934317307775) (10.1016/j.amjmed.2017.07.011))

Timothy Self, Samantha Ellingson

Research output: Contribution to journalComment/debate

Abstract

The authors regret that an error occurred in the table. The dosage for the Ubitron Neohaler (Novartis AG, USA) should have a frequency of twice daily instead of once daily. The Ubitron Neohaler inhaler uses a smaller dosage than the European version (Utibro Breezhaler, Novartis, Basel, Switzerland), which is used once daily. The updated table is provided (Table). The authors apologize for any inconvenience caused.

Original languageEnglish (US)
Number of pages1
JournalAmerican Journal of Medicine
Volume131
Issue number2
DOIs
StatePublished - Feb 1 2018

Fingerprint

Metered Dose Inhalers
Nebulizers and Vaporizers
Bronchodilator Agents
Switzerland
Chronic Obstructive Pulmonary Disease
Emotions
Medicine
corrigendum

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{a72304e857a4409aac6122a9382bb3ea,
title = "Corrigendum to “New Treatment Option for COPD: Two Long-Acting Bronchodilators in a Single Metered Dose Inhaler” (The American Journal of Medicine (2017) 130(11) (1251–1254), (S0002934317307775) (10.1016/j.amjmed.2017.07.011))",
abstract = "The authors regret that an error occurred in the table. The dosage for the Ubitron Neohaler (Novartis AG, USA) should have a frequency of twice daily instead of once daily. The Ubitron Neohaler inhaler uses a smaller dosage than the European version (Utibro Breezhaler, Novartis, Basel, Switzerland), which is used once daily. The updated table is provided (Table). The authors apologize for any inconvenience caused.",
author = "Timothy Self and Samantha Ellingson",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.amjmed.2017.11.006",
language = "English (US)",
volume = "131",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Corrigendum to “New Treatment Option for COPD

T2 - Two Long-Acting Bronchodilators in a Single Metered Dose Inhaler” (The American Journal of Medicine (2017) 130(11) (1251–1254), (S0002934317307775) (10.1016/j.amjmed.2017.07.011))

AU - Self, Timothy

AU - Ellingson, Samantha

PY - 2018/2/1

Y1 - 2018/2/1

N2 - The authors regret that an error occurred in the table. The dosage for the Ubitron Neohaler (Novartis AG, USA) should have a frequency of twice daily instead of once daily. The Ubitron Neohaler inhaler uses a smaller dosage than the European version (Utibro Breezhaler, Novartis, Basel, Switzerland), which is used once daily. The updated table is provided (Table). The authors apologize for any inconvenience caused.

AB - The authors regret that an error occurred in the table. The dosage for the Ubitron Neohaler (Novartis AG, USA) should have a frequency of twice daily instead of once daily. The Ubitron Neohaler inhaler uses a smaller dosage than the European version (Utibro Breezhaler, Novartis, Basel, Switzerland), which is used once daily. The updated table is provided (Table). The authors apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85037728658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037728658&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2017.11.006

DO - 10.1016/j.amjmed.2017.11.006

M3 - Comment/debate

VL - 131

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 2

ER -